Disease ⇒ Urinary stone disease {40000161}

Record Keys

Parent:[  ]
Urinary stone disease


Initialisation date:
Other Terms:
Urinary Calculi, Nephrolithiasis, Stones, Urolithiasis


Meta Information

MedDra ID:[  ]
MedDra Level:[  ]
ICD:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

Shared Reference Notes

  • [1.1
    - Lactobacillus may inhibit stone growth. However, our multi-omics integration strongly points to three unknown metabolites. - The bacterium Oxalobacter formigenes uses oxalate as a carbon and energy source for growth, is negatively associated with both USD and urinary oxalate, is sensitive to common antibiotics, and can reduce urinary oxalate when administered orally as a probiotic, all of which implicates loss of function dysbiosis associated with this species and calcium oxalate stone formation.
  • [1.2] [#Antibiotic Therapy
    - antibiotics cause a rapid loss of gut microbial #oxalate metabolism, and while disturbed bacteria can partially recover over time, the ability to metabolize #oxalate does not. - This results in the accumulation of oxalates in the body and increases the risk of kidney stones.
  • [1.3] [#Kidney stone
  • [1.4] [#Diabetes Type 2, #Gallstone Disease, #Kidney stone
    - #Eggerthella, #Flavonifractor, and #Ruminococcus spp., all of which were enriched in SF, have recently been suggested as general disease-associated signatures (shared across type 2 diabetes, diarrhoea and #Constipation, mental disorders, and gallstones)
  • [1.5] [#Kidney stone, #Urolithiasis
    - no differences in the abundance of genes associated with known #oxalate degradation pathways, supporting the notion that dysfunction in other metabolic pathways plays a role in KSD. - KSD > decreased abundance of key enzymes involved in #Butyrate biosynthesis in patient intestinal microbiomes.

References Notes

[  ]
MetaBiom only uses strictly necessary session cookies to give you the best possible experience on the website. By selecting "Accept essential cookies" you agree to the use of these cookies.